# Inductive Bio

**Canonical:** https://apis.io/providers/inductive-bio/  
**Website:** https://www.inductive.bio/  
**APIs profiled:** 0

Inductive Bio is an AI-powered virtual lab for small molecule drug discovery, based in New York and founded in 2022 by Josh Haimson and Ben Birnbaum (both formerly of Flatiron Health). The company pairs medicinal chemists with machine learning to run millions of in silico ADMET (Absorption, Distribution, Metabolism, Excretion, Toxicity) experiments, surface the strongest compound hypotheses, and accelerate the path to development candidates. Its Beacon-1 models took first place in both the 2025 Polaris/ASAP and 2026 OpenADMET/ExpansionRx blind ADMET competitions, and are delivered through the Compass software platform (with the Indy AI chemistry assistant) and an Embedded Experts services offering. Inductive Bio operates a pre-competitive ADMET data consortium, is SOC 2 compliant, and is backed by a16z, Lux Capital, Bessemer Venture Partners, Obvious Ventures, Character, and S32. Compass is enterprise/partner software; it exposes an API to partner teams but publishes no public, self-serve developer portal, OpenAPI, or SDK.

## Kin Score — 13.2 / 100 (emerging)

Scored 2026-08-20 under rubric 0.12.0. Trend: flat (+0.0 from 13.2).

| Facet | Score |
|---|---|
| Discoverability | 57.4 |
| Contract Quality | 0.0 |
| Governance | 18.2 |
| Contract Governance | 18.2 |
| Operational Transparency | 2.6 |
| Developer Ergonomics | 2.4 |
| Commercial Clarity | 21.1 |
| Access Clarity | 21.1 |

Regulatory layer — **Health**: 20.0 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Security (1)

- **Inductive Bio Domain Security** — TLSv1.3 · HSTS · DMARC

## Tags

Company, Drug Discovery, Machine-Learning, Artificial Intelligence, ADMET, Small Molecule, Computational Chemistry, Life Sciences, Biotech, Pharmaceuticals

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/inductive-bio/). Scores are computed from the provider's own public artifacts under a published rubric.